![[IPWatchdog Logo]](https://ipwatchdog.com/wp-content/themes/IPWatchdog%20-%202023/assets/images/temp/logo-small@2x.png){kind=logo}
Erik Iverson
Chief Executive Officer
Wisconsin Alumni Research Foundation
Erik Iverson is Chief Executive Officer of the Wisconsin Alumni Research Foundation (WARF), a nonprofit, mission-driven organization supporting scientific research within the UW–Madison community for nearly a century. He joined WARF in June 2016. WARF is the designated patent management organization for UW, partnering with university researchers on patenting and licensing their discoveries and providing grants to the UW to support further research.
Iverson has over 20 years of executive experience leading organizations and programs committed to entrepreneurial efforts that positively impact people worldwide. Prior to joining WARF, he served as a lead executive at the Infectious Disease Research Institute (IDRI), attorney at the Bill & Melinda Gates Foundation and within the law firm of Perkins Coie.
He holds a B.A. from Gustavus Adolphus College, J.D. from the University of North Dakota, and an LL.M. from New York University.
Recent Articles by Erik Iverson
IDRI granted license rights to its world-class vaccine adjuvants to Immune Design Corporation (IDC), which was established in Seattle in 2008 with a focus on cancer, allergies and certain infectious diseases. The royalties and other funds received from IDC have helped to support IDRI’s programs, and IDC’s clinical safety data relating to the adjuvants have been vital in IDRI’s ability to accelerate the development of vaccines for tuberculosis and leishmaniasis, two diseases with an immense global health burden.
